Abstract：Ulcerative colitis(UC)is a chronic and recurrent colitis disease.Its etiology and pathogenesis is not entirely clear yet.At present,UC is considered to be related to multiple factors and multiple links.Aminosalicylates and glucocorticoids were the first choice to treat UC.Immunosuppressants is mostly used in severe refractory UC,and the effect is accurate,but the adverse reaction is obvious.Antibiotics,microecologics,biologics and traditional Chinese medicine can also play a role in the treatment of UC.This review will summarize the pathogenesis and drug treatment of UC.
何晓瑞. 溃疡性结肠炎的发病机制和药物治疗的研究进展[J]. 中国当代医药, 2018, 25(7): 25-27.
HE Xiao-rui. Research progress on pathogenesis and drug treatment of ulcerative colitis. 中国当代医药, 2018, 25(7): 25-27.
AnanthakrishnanAN，McGinleyEL，BinionDG.Excesshospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease[J].Gut，2008，57（2）：205.
[7]
欧阳钦.溃疡性结肠炎的治疗[J].中国实用内科杂志，2011，30（4）：383-385.
[8]
田士军.溃疡性结肠炎的药物治疗进展[J].医学综述，2009，15（17）：2612-2614.
[9]
蒋蔚茹.炎症性肠病的认识与药物治疗进展[J].上海医药，2010，31（5）：208-210.
[10]
Prefontaine E，Macdonald JK，Sutherland LR.Azathioprine or 6-mercaptopurine for induction of remission in Crohn′s disease[J].Cochrane Database Syst Rev，2010，16（6）：CD00 0545.
Cassinotti A，Actis GC，Duca P，et al.Maintenance treatment with azathioprine in ulcerative colitis：outcome and predictive factors after drug withdrawal[J].Am J Gastroenterol，2009，104（11）：2760-2767.
京公网安备 11010502046607号